Navigation Links
Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
Date:9/20/2013

NEW YORK, Sept. 20, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Transcept Pharmaceuticals, Inc. ("Transcept" or the "Company") (NASDAQ: TSPT) concerning the proposed acquisition of the Company by Retrophin, Inc. ("Retrophin").    

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

Retrophin has offered to acquire Transcept for $4.00 per share.  The Transcept board recently adoped a "tax benefit preservation plan" which may have been designed to stymie Retrophin's acquisition attempt.

Our investigation concerns whether the Transcept board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own Transcept shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin I. Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individu
'/>"/>

SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
2. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
3. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
5. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
6. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
7. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
8. OPTIMIZERx Corporation Announces the Resignation of the Companys Current CEO & Chairman Mr. Shadron L. Stastney
9. Abaxis Announces Management Transition
10. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
11. FDAnews Announces Medical Device Mobile Apps Virtual Conference - Oct. 3, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... Colorado (PRWEB) , ... June 29, 2015 , ... ... Association (NENA) Annual Conference shows that fewer than 10 percent of U.S. state ... percent of organizations have set an implementation deadline for NG9-1-1. , “Mobile ...
(Date:6/29/2015)... ... June 29, 2015 , ... Celebrities have many skincare secrets, and ... skin all summer long and beyond. People don’t have to be famous to ... aging process, maintain an even skin tone, avoid breakouts, and take skin health and ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... and behavior, is a popular focus for corporate training seminars. As many as ... practices, improve training, foster teamwork, and increase productivity. , With the demand ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... pharmacist guided, safe, informed, responsible and legal access to Health Canada's medical cannabis ... , NAC provides education on how Health Canada's medical marijuana system works. Members ...
(Date:6/29/2015)... ... June 29, 2015 , ... BaliniSports has been announced as an official sponsor ... later this year. This year’s contestants will be wearing pieces from the BaliniSports collection ... competition will go on to represent the state in the Miss Teen USA competition. ...
Breaking Medicine News(10 mins):Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
... the Bench,-, EL SEGUNDO, Calif., Oct. 16 ... solutions for microarray-based,research, announced today the release of ... that provides easy, fast and powerful platform,independent and ... data sets, simultaneously. NEXUS CGH easily supports ...
... The department of bioengineering at Clemson University has received ... Both the National Institutes of Health (NIH) and a ... (NSBRI www.nsbri.org ), are primary contributors of funds ... application. , The study addresses bone loss that occurs ...
... YORK, Oct. 16 Even though Americans pick up ... toothbrushes,may need a cleaning of their own. Celebrity Dentist ... says a new survey conducted by the,Philips Sonicare brand ... Listen to this report from Philips (NYSE: ...
... Unique Request Highlights December 2 Annual Wells Fargo Walk of Ages ... ... Home is,inviting everyone with the name of "Walker" in the United States to ... Walk of,Ages" on December 2 in Reseda. According to official census records there,are ...
... - BCL.P, VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ ... announce that it has entered into an ... (the "Arrangement,Agreement") with iCo Therapeutics Inc. ("iCo"). ... constitute Beanstalk,s,"Qualifying Transaction" as a capital pool ...
... children appear to have a lower risk of asthma ... a non-agricultural rural environment, according to a University of ... 13,524 asthmafree children aged less than 12 years in ... Youth (NLSCY) showed that children living in a farming ...
Cached Medicine News:Health News:BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization 2Health News:Clemson awarded $2M to study radiation-induced bone loss 2Health News:FORGET THE JONESES, This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named 'Walker' in the United States 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 3Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 4Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 5Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 6Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 7Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 8Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 9Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 10Health News:Farm kids have lower risk of asthma, study shows 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: